Omega-3 fatty acids' supplementation in Parkinson's disease: A systematic review of randomized controlled trials
-
Published:2024-06
Issue:
Volume:55
Page:102-115
-
ISSN:2667-2685
-
Container-title:Clinical Nutrition Open Science
-
language:en
-
Short-container-title:Clinical Nutrition Open Science
Author:
Detopoulou ParaskeviORCID,
Voulgaridou Gavriela,
Saridaki AlexandraORCID,
Argyris Elissaios- MinosORCID,
Seva Vasiliki,
Dedes VasiliosORCID,
Giaginis Constantinos,
Panoutsopoulos Georgios I.,
Papadopoulou Sousana K.
Reference49 articles.
1. Omega-3 polyunsaturated fatty acids and their health benefits;Shahidi;Annu Rev Food Sci Technol,2018
2. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance;Calder;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,2015
3. Depression in Parkinson’s disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation;Da Silva;Journal of Affective Disorders,2008
4. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial;Taghizadeh;Neurochemistry International,2017
5. Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats with Parkinson-Like Pathology;Chang;Cell Transplant,2012